Effectiveness of Agomelatine in Generalized Anxiety Disorder Comorbid to Bipolar 1 Disorder in a Male Adolescent Patient
Anxiety comorbidity in bipolar disorder (BD) is important and thus significantly affects the course of BD and its outcomes. The treatment of generalized anxiety disorder comorbid with BD involves certain challenges, as antidepressant medications, which are standard in the treatment of anxiety disorder, have the risk of shifting to manic episodes and rapid cycling. In this case report, the response to agomelatine treatment in generalized anxiety disorder comorbid with bipolar 1 disorder was evaluated.
Authors
- İbrahim Adak (ORCID: https://orcid.org/0000-0001-9057-9017)
- A. Ş. Kaçar (ORCID: https://orcid.org/0009-0003-5111-8754)
- Oğuz Bilal Karakuş (ORCID: https://orcid.org/0000-0001-6623-7375)
- Zeynep Ece Aydın (ORCID: https://orcid.org/0009-0005-5349-3181)
Institutions
- Bakırköy Psychiatric Hospital (TR)
- Uni Research (Norway) (NO)
Publication Details
- Journal
- Clinical Neuropharmacology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1097/wnf.0000000000000604
- Citations
- 1
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39